National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

NBI-3001

 A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. NBI-3001 is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL immunotoxin and interleukin-4 PE38KDEL cytotoxin.



Previous Definitions:natural history study, natural killer cell, naturopathy, nausea, NB1011
Next Definitions:NCCAM, NCI, NCI clinical trials cooperative group, NCX 4016, NDGA

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov